Description
INPPL1 Antibody | 13-439 | Gentaur UK, US & Europe Distribution
Host: Rabbit
Reactivity: Human, Mouse, Rat
Homology: N/A
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 100-310 of human INPPL1 (NP_001558.3) .
Research Area: Cancer, Cell Cycle, Growth Factors, Immunology, Neuroscience, Signal Transduction
Tested Application: WB
Application: WB: 1:500 - 1:2000
Specificiy: N/A
Positive Control 1: HeLa
Positive Control 2: U-251MG
Positive Control 3: A-549
Positive Control 4: BT-474
Positive Control 5: Mouse heart
Positive Control 6: Mouse brain
Molecular Weight: Observed: 160kDa
Validation: N/A
Isoform: N/A
Purification: Affinity purification
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Concentration: N/A
Storage Condition: Store at -20˚C. Avoid freeze / thaw cycles.
Alternate Name: OPSMD, SHIP2, phosphatidylinositol 3, 4, 5-trisphosphate 5-phosphatase 2, 51C protein, INPPL-1, SH2 domain-containing inositol-5'-phosphatase 2, SHIP-2, protein 51C
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: The protein encoded by this gene is an SH2-containing 5'-inositol phosphatase that is involved in the regulation of insulin function. The encoded protein also plays a role in the regulation of epidermal growth factor receptor turnover and actin remodelling. Additionally, this gene supports metastatic growth in breast cancer and is a valuable biomarker for breast cancer.